Rapid Coagulation Testing Market

Rapid Coagulation Testing Market Overview

The global rapid coagulation testing market size is set to reach US$ 8.6 Billion in 2032 and exhibit growth at an astonishing CAGR of 4.5% in the forecast period from 2022 to 2032. It is anticipated to be valued at US$ 3.7 Billion in 2022. The emergence of smartphone-based blood coagulation tests in developed countries is projected to propel the demand for rapid coagulation testing devices in future years.

Report Attribute	Details
Rapid Coagulation Testing Market Estimated Base Year Value (2021)	US$ 2.1 Billion
Rapid Coagulation Testing Market Expected Market Value (2022)	US$ 3.7 Billion
Rapid Coagulation Testing Market Anticipated Forecast Value (2032)	US$ 8.6 Billion
Rapid Coagulation Testing Market Projected Growth Rate (2022-2032)	4.5% CAGR

Rapid coagulation testing is referred to as the rapid specific testing of blood fluids at an individual’s bedside. The extensive usage of these tests for the management of perioperative coagulation is estimated to drive the growth in this market.

These help in reducing inappropriate transfusion and provide results in minutes. Two methods, namely, viscoelastic and aggregometry are mainly deployed for this type of testing.

Viscoelastic rapid coagulation methods are used to find detailed information about every aspect of coagulation, such as plasma and cellular components of whole blood. The aggregometry rapid coagulation method, on the other hand, is employed to analyze and monitor whole blood.

The ongoing development of personalized medicine and the urgent need to manage bleeding patients are expected to aid the growth in this market. In addition to that, the surging prevalence of cancer among the geriatric population is likely to fuel the growth.

Which are Some Prominent Drivers Spearheading Rapid Coagulation Testing Market Growth?

The surging demand for coagulation laboratory and special hematology is estimated to augment the rapid coagulation testing market growth in the evaluation period. The ongoing development of various advanced technologies, such as photoacoustic detection, electrochemical sensing, microfluidics, and fluorescent microscopy is also expected to bode well for the market.

These technologies are likely to be utilized for the development of highly robust and cost-effective Point-of-Care (POC) devices. The ability of these devices to measure electrochemical, mechanical, and optical parameters of clotting blood is anticipated to fuel the market. Also, the increasing prevalence of chronic blood diseases and cardiovascular issues is another vital factor that is set to drive the market.

What are the Challenges Faced by the Rapid Coagulation Testing Industry?

Non-hematological staff members require competency and training to perform rapid coagulation tests. As compared to conventional testing, rapid coagulation tests are more expensive. Besides, these measure coagulations under artificial conditions and quality assurance standards are difficult to institute outside the laboratory. Spurred by the aforementioned factors, sales of rapid coagulation testing devices may be hampered in the evaluation period.

Why is Europe Emerging as an Opportunistic Rapid Coagulation Testing Market?

Europe is expected to remain at the forefront by generating the largest rapid coagulation testing market share in the assessment period. This growth is mainly attributable to the increasing technological advancement in the healthcare sector, especially in the U.K. and Germany.

The surging death rates due to strokes and ischaemic heart disease in Eastern and central Europe are likely to accelerate the need for rapid coagulation testing devices in future years. Increasing expenditure in healthcare and the availability of cutting-edge medical equipment across Europe are a couple of other factors that are set to spur the market.

How is Asia Pacific Contributing to Growth of the Rapid Coagulation Testing Market?

The increasing adoption of sedentary lifestyles and the rising demand for foreign investments in China and India are anticipated to bolster the Asia Pacific rapid coagulation testing market growth in the forthcoming years. The surging number of road accidents in these countries are expected to lead to the occurrence of harmful injuries, such as head trauma and blood clots. These are further likely to propel the need for rapid coagulation testing across Asia Pacific.

According to the India Brand Equity Foundation (IBEF), FDI inflows for the pharmaceuticals and drugs sector stood at US$ 18.12 billion between April 2000 and June 2021. The central government also established 638 e-hospitals across India to accelerate its ‘Digital India’ initiative. Thus, rising government spending on the development of healthcare infrastructure is projected to push the market in Asia Pacific.

Market Competition

Some of the renowned companies operating in the global rapid coagulation testing market include Entegrion, Inc., Abbott, Danaher, Medtronic, Siemens Healthcare Private Limited, F. Hoffmann-La Roche, Sysmex Corporation, Universal Biosensors, Helena Laboratories, Rapid Diagnostics Group of Companies, and Thermo Fisher Scientific among others.

Majority of the leading players in the market are striving to gain fast track approval from regulatory bodies, such as the U.S. FDA to market and distribute their products worldwide. A few other companies are aiming to diversify their existing portfolios by launching innovative products. Meanwhile, some of the local and start-up companies are engaging in acquisitions and partnerships to co-develop new products and cater to the ever-increasing demand from customers globally.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 4.5% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015-2020
Forecast Period	2022-2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Product Type Method Type End User Region
Regions Covered	North America Latin America Western Europe Eastern Europe APEJ Japan Middle East and Africa
Key Countries Profiled	U.S Canada Brazil Argentina Germany U.K France Spain Italy Nordics BENELUX Australia & New Zealand China India ASEAN GCC South Africa
Key Companies Profiled	Entegrion, Inc. Abbott Danaher Medtronic Siemens Healthcare Private Limited F. Hoffmann-La Roche Sysmex Corporation Universal Biosensors Helena Laboratories Rapid Diagnostics Group of Companies Thermo Fisher Scientific
Customization	Available Upon Request

Key Segments Profiled in the Rapid Coagulation Testing Industry Survey

Product Type:

• Instruments
• Coagulation Analyzers
• Cartridges
• Accessories and Disposables
• Calibrators and Controls
• Reagents

By Method Type:

• Aggregometric
• Viscoelastic

By End User:

• Hospitals
• Clinics
• Diagnostic Laboratories
• Home Care Settings

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East and Africa